Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
-
May
-
June
-
July
-
August
-
September
-
Oktober
-
November
- December |
2002
-
2003
- 2004 -
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
-
2025
December 2004 - 16 products
L
SIP
IP
CI
Avastin 100 mg/4 ml
Durchstechflasche(n)
283.32
322.95
10 %
Concentrate for infusion: Bevacizumabum 100mg / 4ml
Roche Pharma
(Schweiz) AG
A / SL
FB
G
L
SIP
IP
CI
Avastin 400 mg/16 ml
Durchstechflasche(n)
1059.11
1162.35
10 %
Concentrate for infusion: Bevacizumabum 400mg / 16ml
Roche Pharma
(Schweiz) AG
A / SL
FB
G
IP
CI
Claritine Pollen
10 Tablet(s)
PR
PR
k.A.
Tablets: Loratadinum 10 mg
Bayer (Schweiz) AG
D
FB
G
IP
CI
Clopin eco 25
-
T
50 Tablet(s)
7.03
16.85
10 %
Tablets: Clozapinum 25 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
CI
Clopin eco 100
-
T
50 Tablet(s)
18.50
36.55
10 %
Tablets: Clozapinum 100 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
CI
Combigan
5 ml
12.71
30.25
10 %
Eye drops: 2 Active Agents
AbbVie AG
B / SL
FB
G
IP
CI
Combigan
3 x 5 ml
36.22
55.80
10 %
Eye drops: 2 Active Agents
AbbVie AG
B / SL
FB
G
IP
CI
Osteocal D3 1200/800
10
PR
PR
k.A.
Dr. Heinz Welti AG,
Fabrikation chemisch-
pharmazeutischer
Produkte
D
FB
G
IP
CI
Osteocal D3 1200/800
20
7.05
13.00
10 %
Dr. Heinz Welti AG,
Fabrikation chemisch-
pharmazeutischer
Produkte
● 
D / SL
FB
G
IP
CI
Osteocal D3 1200/800
40
12.41
22.90
10 %
Dr. Heinz Welti AG,
Fabrikation chemisch-
pharmazeutischer
Produkte
● 
D / SL
FB
G
SIP
IP
CI
Relestat
5 ml
7.75
17.65
10 %
AbbVie AG
B / SL
FB
G
SIP
IP
Primovist 0.25 mmol/ml
syringe(s)
158.40
188.70
10 %
Injection solution: Dinatrii Gadoxetas 181.43 mg/ml
Bayer (Schweiz) AG
B / SL
FB
G
SIP
IP
Primovist 0.25 mmol/ml
PR
PR
k.A.
Injection solution: Dinatrii Gadoxetas 181.43 mg/ml
Bayer (Schweiz) AG
B
FB
G
IP
Gluscan
/ 10 ml
PR
PR
k.A.
: 2 Active Agents
ADVANCED ACCELERATOR
APPLICATIONS
INTERNATIONAL SA
A
FB
G
IP
Eligard 22.5 mg
311.35
355.05
10 %
: Leuprorelini Acetas 22.5 mg
Recordati AG
A / SL
FB
G
IP
Eligard 7.5 mg
103.79
129.30
10 %
: Leuprorelini Acetas 7.5 mg
Recordati AG
A / SL
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home